European men show strong interest in upcoming male contraceptive options
A survey of 14,000 men across seven European countries found that most would adopt new male contraceptives within a year of approval.
A recent survey of 14,000 men in seven European nations showed that more than half would begin using a newly approved male contraceptive within twelve months, while just 9% would refuse any such product. Interest was highest in the United Kingdom (69%) and lowest in Sweden and Denmark (55%). The most popular concept was a non-hormonal pill taken shortly before intercourse, followed by a daily pill, with a vas-occlusive hydrogel and a thermal silicone ring also gaining support in specific countries.
Funding gaps, largely due to limited pharmaceutical involvement, were identified as the chief barrier to development. Experts highlighted that greater male autonomy and reduced reliance on condoms or female methods drive the demand. The World Health Organization released new target product profiles aimed at expanding male contraceptive choices, aligning with the survey’s findings.
Why it matters
Understanding male demand for contraception can shape funding and policy to broaden birth-control options for both genders.
In this story
